Missling states they have $150 million in cash.
Gathering clinical data to submit to FDA in order to meet with FDA regarding Retts. And
Alzheimers last patient data should be completed in summer therefore still expects a readout in late 2022.
Discussed markets are billions, even Retts.
told ananlyst they were submitting data on Rett trial, not waiting for pediatric study